World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

3347

Figures (1-2)

365

Tables (1-1)

394

Sum=4195

Publishing Process of This Article

Item

Count

Browse

135

Download

441

Sum=576

Jun 14, 2024 (publication date) through Jul 2, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Vootukuru N, Vasudevan A. Approach to loss of response to advanced therapies in inflammatory bowel disease. World J Gastroenterol 2024; 30(22): 2902-2919 [PMID: 38947290 DOI: 10.3748/wjg.v30.i22.2902]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i22/2902.htm

Number	Citing Articles
1	Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease. World Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825 Abstract(333) \| Core Tip(349) \| Full Article(HTML)(1078) \| Full Article with Cover (PDF)-676K(57) \| Audio-180K(8) \| Peer-Review Report-176K(51) \| Answering Reviewers-141K(46) \| Full Article (PDF)-399K(75) \| Full Article (XML)-102K(47) \| Times Cited (0) \| Total Visits (2490) \| Open
2	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(548) \| Core Tip(572) \| Full Article(HTML)(1041) \| Full Article with Cover (PDF)-639K(81) \| Audio-785K(10) \| Peer-Review Report-230K(59) \| Answering Reviewers-209K(61) \| Full Article (PDF)-410K(85) \| Full Article (XML)-117K(61) \| Times Cited (0) \| Total Visits (3488) \| Open
3	J. Bronsky, K. Zarubova, I. Copova, M. Durilova, D. Kazeka, M. Kubat, T. Lerchova, K. Mitrova, E. Vlckova, J. Duskova, J. Dostalikova, O. Hradsky. Association of Serum Levels of Ustekinumab, Vedolizumab, and Faecal Calprotectin in Paediatric Patients with Inflammatory Bowel Diseases: A Prospective Observational Study. Pediatric Drugs 2025; doi: 10.1007/s40272-025-00702-9